Representative Matters
代表事项
REFERENZMANDATE
Mergers & Acquisitions
- edX Inc. in its strategic transaction with 2U, Inc.
- Fleetmatics Group PLC in its $2.4 billion sale to Verizon
- AppNexus in its sale to AT&T
- Landmark Bio, in a joint venture formation between Harvard University, Fujifilm Diosynth Biotechnologies, Cytiva, and Alexandria Real Estate Equities
- New Euro-Pro Holdings LLC (d/b/a “SharkNinja”) in an investment by CDH Investments
- 6 River Systems, Inc. in its $450 million sale to Shopify Inc.
- Boston Dynamics in its acquisition by Google, Inc.*
- Continuum Managed Services in its sale to Thoma Bravo, and subsequent sale to ConnectWise, LLC.
- Continuum Managed Services in its acquisitions of BrightGauge Software Inc. and Carvir, LLC
- Steward Health Care Systems LLC in its acquisition of New England Sinai Hospital*
- Sansoro Health, Inc. in its acquisition of Datica Health, Inc.
- Evariant, Inc., in its sale to Healthgrades
- ANSYS, Inc. in its investment in 3DSIM, LLC
- PTC Inc. in its acquisition of Enigma*
- Nova Ventures Group in its acquisitions of multiple portfolio companies in the sensors industry
- Alkermes plc. in its $50 million sale of a division to Recro Pharma, Inc.
- GnuBio Inc. in its sale to Bio-Rad Laboratories, Inc.*
- Viracor-IBT in its $255 million sale to Eurofins Scientific*
- Essilor International in its acquisition of Costa Inc.*
- Perfumania Holdings, Inc. in its registration of securities on Form S-4 in connection with its acquisition of Parlux Fragrances, Inc.*
Venture Capital
- Bessemer Venture Partners in investments in early-stage technology companies
- A FinTech investment fund in a wide range of investments into FinTech portfolio companies
- General Catalyst Partners in investments in entrepreneur-in-residence investment vehicles
- Matrix Partners in investments in early-stage technology companies
- Optum Venture Partners in investments in portfolio companies
- Will Ventures in investments in portfolio companies at the intersection of sports and technology
- Romulus Capital in investments in Ceres Imaging, Cogito, Cohealo, Disruptor Beam, E la Carte, EquipmentShare.com, Humanyze, Petagene, Placester, and Vyome Biosciences
- BioInnovation Capital in investments in early-stage life sciences companies
- Flare Capital Partners in its investment in Bright Health
- Charles River Ventures in its Series A investment in a technology company*
- Ascension Ventures in its investments in Atigeo, Inc. and Syapse, Inc.
- Startup Institute in its Series B equity financing
- Open Door Trading LLC in its equity financings
- Alkermes plc in its investment in ReSet Therapeutics, Inc.
- Serenity Pharmaceuticals LLC in its Series C equity financing
- Viamet Pharmaceuticals in its Series C equity financing*
- Asahi Kasei Corporation in its investment in Hydro-Photon, Inc.
General Business Matters
Mr. Reardon advises a variety of public and private technology and life sciences clients, including BATON Financial Services, edX Inc., Landmark Bio, Mercy Bioanalytics, Inc., SEMrush, Virex Health, Inc., and THINKMD, PBC, on general business and corporate matters.
Professional Experience
- Mr. Reardon co-taught "Forming and Financing a Start-Up Business," a semester-long course in the Transactional Law Program at the Boston University School of Law.
- Mr. Reardon serves as a mentor a judge in the MIT $100K Entrepreneur Competition.
- Mr. Reardon leads mock negotiation sessions for the MIT Sloan School of Management course "Early Stage Capital."
- Mr. Reardon is actively involved in pro bono matters, serving as outside general counsel for THINKMD, Inc., a public benefit corporation that has deployed a free screening assessment and education tool to monitor the COVID-19 pandemic spread and response. Read more about their efforts here.